Nanoparticle Therapy for Vascular Diseases

Arteriosclerosis, Thrombosis, and Vascular Biology
Alyssa M FloresNicholas J Leeper

Abstract

Nanoparticles promise to advance strategies to treat vascular disease. Since being harnessed by the cancer field to deliver safer and more effective chemotherapeutics, nanoparticles have been translated into applications for cardiovascular disease. Systemic exposure and drug-drug interactions remain a concern for nearly all cardiovascular therapies, including statins, antithrombotic, and thrombolytic agents. Moreover, off-target effects and poor bioavailability have limited the development of completely new approaches to treat vascular disease. Through the rational design of nanoparticles, nano-based delivery systems enable more efficient delivery of a drug to its therapeutic target or even directly to the diseased site, overcoming biological barriers and enhancing a drug's therapeutic index. In addition, advances in molecular imaging have led to the development of theranostic nanoparticles that may simultaneously act as carriers of both therapeutic and imaging payloads. The following is a summary of nanoparticle therapy for atherosclerosis, thrombosis, and restenosis and an overview of recent major advances in the targeted treatment of vascular disease.

References

May 13, 2003·Clinical Pharmacokinetics·Alberto GabizonYechezkel Barenholz
May 17, 2003·Nature Reviews. Drug Discovery·Ruth Duncan
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Dec 27, 2005·Current Cancer Drug Targets·Józef Dulak, Alicja Józkowicz
Mar 28, 2006·Nature·Tracy S ZimmermannIan MacLachlan
Jul 11, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Patrick M WinterGregory M Lanza
Jan 11, 2007·Journal of Vascular Surgery·Benjamin J DunmoreNicholas P J Brindle
May 24, 2007·British Journal of Cancer·T Kamba, D M McDonald
Dec 26, 2007·Circulation·Matthias NahrendorfRalph Weissleder
Feb 23, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Tillmann CyrusGregory M Lanza
May 17, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·James H F RuddZahi A Fayad
Aug 9, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Michael JonerRenu Virmani
Aug 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Maria Frank-KamenetskyKevin Fitzgerald
Sep 6, 2008·Nature Nanotechnology·Adam De la ZerdaSanjiv S Gambhir
Nov 11, 2008·Nature·Joshua I GreenbergDavid A Cheresh
Dec 6, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·David P CormodeWillem J M Mulder
Jan 16, 2009·Vascular Medicine·Eser AdiguzelMichelle P Bendeck
Apr 10, 2009·JACC. Cardiovascular Imaging·Patrick M WinterGregory M Lanza
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierRonald M Bukowski
Aug 8, 2009·Journal of the American College of Cardiology·Shao-Ling HuangDavid D McPherson
Feb 5, 2010·JACC. Cardiovascular Imaging·Mario GösslAmir Lerman
Apr 21, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michael ChornyRobert J Levy
Mar 15, 2011·Journal of Lipid Research·Marija Tadin-StrappsLyndon J Mitnaul
Apr 22, 2011·Nanomedicine·Jon N MarshGregory M Lanza
May 3, 2011·Cell·Kathryn J Moore, Ira Tabas
Oct 11, 2011·Nature Biotechnology·Florian LeuschnerMatthias Nahrendorf
Oct 15, 2011·Journal of Atherosclerosis and Thrombosis·Seigo MasudaKensuke Egashira
Nov 17, 2011·Proceedings of the National Academy of Sciences of the United States of America·Juliana M ChanOmid C Farokhzad
Mar 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Stephen B WillinghamIrving L Weissman
Apr 10, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yechezkel Barenholz
Aug 17, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Peter Libby
Nov 20, 2012·Journal of the American College of Cardiology·Hiroyuki KawataYoshihiko Saito
Jan 15, 2013·Journal of the American Heart Association·Hisanori KosugeMichael V McConnell
Apr 23, 2013·Journal of Vascular Surgery·Stephen M SeedialK Craig Kent

❮ Previous
Next ❯

Citations

Jan 26, 2020·International Journal of Molecular Sciences·Jiansheng HuangHui Huang
Mar 17, 2020·Future Medicinal Chemistry·Yee-Hung Chan, Dipak P Ramji
Apr 5, 2020·Nanomaterials·Shi Su, Peter M Kang
Jun 18, 2020·International Journal of Nanomedicine·Rajasekharreddy PalaSurya M Nauli
Aug 10, 2019·Current Pathobiology Reports·Ana CartayaEdward M Bahnson
Feb 29, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tobias LenzMichael Joner
Jan 7, 2021·Expert Opinion on Drug Delivery·Andrea PerrelliSaverio Francesco Retta
Jan 20, 2021·ACS Biomaterials Science & Engineering·Erica B Peters, Melina R Kibbe
Mar 14, 2021·Nanomedicine : Nanotechnology, Biology, and Medicine·Eugenia BelcastroValérie B Schini-Kerth
Sep 11, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yin DouJianxiang Zhang
May 13, 2021·Nature Reviews. Drug Discovery·Oliver Soehnlein, Peter Libby
Jan 28, 2020·ACS Nano·Yogendra KanthiBryan Ronain Smith
Oct 15, 2021·ACS Nano·Hui ChenJiangfan Yu
Oct 29, 2020·Current Drug Targets·Selvakumar MurugananthamRuckmani Kandasamy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here